Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Seminars in Cancer Biology|March 18, 2014
Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agentsJoel G Turner, Jana Dawson, Christopher L Cubitt, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 13, 2010
Prediction of response and progression in multiple myeloma with serum free light chains assay: corroboration of the serum free light chain response definitionsRami Khoriaty, Mohamad A Hussein, Beth Faiman, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 4, 2011
Gamma-secretase inhibitor enhances the cytotoxic effect of bortezomib in multiple myelomaFeng Chen, Alexandra Pisklakova, Ming Li, et al.
The Journal of Clinical Investigation|September 8, 2007
G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cellsVenugopalan Cheriyath, Keith B Glaser, Jeffrey F Waring, et al.
Acta Oncologica (Stockholm, Sweden)|June 5, 2020
Patient-reported outcomes regarding radiation therapy in patients with multiple myelomaRonica Nanda, David Boulware, Rachid Baz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2013
Therapeutic advances in the treatment of primary plasma cell leukemia: a focus on hematopoietic cell transplantationTaiga Nishihori, Sarah M Abu Kar, Rachid Baz, et al.
Leukemia & Lymphoma|December 11, 2007
Combination of rituximab and oral melphalan and prednisone in newly diagnosed multiple myelomaRachid Baz, Suzanne Fanning, Lori Kunkel, et al.
Hemasphere|January 12, 2026
Navigating the evolving management of smoldering multiple myelomaM Bakri Hammami, Rafael R Canevarolo, Ariosto S Silva, et al.
Medical Oncology (Northwood, London, England)|May 25, 2006
Efficacy and safety results with the combination therapy of arsenic trioxide, dexamethasone, and ascorbic acid in multiple myeloma patients: a phase 2 trialRony M Abou-Jawde, Janice Reed, Megan Kelly, et al.
Cancer|August 29, 2007
Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemiaRachid Baz, Cristina Rodriguez, Alex Z Fu, et al.
Pageof 9